The flow cytometry staining confirmed that the IGF2BP2 deficiency significantly decreased the human CD45+ leukemia burden in the bone marrow, spleen and peripheral blood (Fig. 5C & Supplementary Fig. 8D). Here, PTPRC is linked to leukemia.